Sign Up to like & get
recommendations!
0
Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-204966
Abstract: Background: The 5th edition of the WHO Classification of Haematolymphoid Tumours (WHO 2022) highlights the importance of cytogenetic and molecular abnormalities in AML as disease-defining criteria. Mutations in genes frequently mutated in clonal hematopoiesis (CH)…
read more here.
Keywords:
aml defining;
group;
clonal hematopoiesis;
pml rara ... See more keywords